ViaCyte Raises $10M, Moves to Human Trial with New Diabetes Product - Xconomy


Xconomy

ViaCyte Raises $10M, Moves to Human Trial with New Diabetes Product
Xconomy
San Diego-based ViaCyte said it is ready to move into human testing with a new product intended for patients with Type 1 diabetes who are at high risk for acute, life-threatening complications from severe episodes of low blood sugar (hypoglycemia ...

and more »